|
|
|
|
|
by angelzen
1709 days ago
|
|
CDC has instituted a policy where vaccinated people were instructed to test on symptoms, whereas unvaccinated people were instructed to test on contact with infected person. In a frontline healthcare setting, workers are constantly in contact with infected persons, thus the difference in testing regimens is maximized. Given that asymptomatic cases are a majority of the cases, such skewed data collection process will result in significant data taint. The faulty policy was active March-July 2021. TLDR. Any study making 'vaccine effectiveness against infection' claims based on US data overlapping March-July 2021 is subject to potential data taint and perhaps should be retracted. I'd rather look elsewhere for reliable epidemiological data. https://jamanetwork.com/journals/jama/fullarticle/2777536 https://archive.is/PB8Q6/again?url=https://www.nytimes.com/l... |
|
I don’t see how this claim is supported by data. The studies referenced showed the vaccine was less effective (vs control) for frontline healthcare workers than the general population (80% vs 95%). If the data were really tainted as you claim, and there is systematic undercounting of asymptomatic breakthrough cases, we would expect the vaccine to perform as well or better in a frontline setting as it does in the general population.
My point was that the parent blatantly misrepresented the results of this study to make a point supporting anti-vaxx positions. Why is this necessary?